Navigation Links
FDA Issues Another Warning on Fake Version of Cancer Drug Avastin
Date:2/6/2013

WEDNESDAY, Feb. 6 (HealthDay News) -- Doctors need to be on the lookout for another counterfeit version of the injectable cancer drug Avastin (bevacizumab), the U.S. Food and Drug Administration warned on Wednesday.

Lab tests revealed that at least one batch of the counterfeit medicine -- distributed by the U.S. company Medical Device King (also known as Pharmalogical) -- contains no active ingredient.

The counterfeit bevacizumab is marketed as Roche's Altuzan, which is not approved for sale in the United States, the FDA noted. The only approved version of bevacizumab for sale in the United States is Avastin, which is marketed by Genentech.

Altuzan 400 mg/16 mL may be counterfeit if it is labeled as batch B6022B01 with an expiration date of November 2013 or batch B6024B01 with an expiration date of February 2013, the agency said.

The FDA also warned doctors, hospitals and patients to "be wary if the price of a medicine sounds too good to be true. Deep discounts may be offered because the product is stolen, counterfeit, substandard or unapproved."

The FDA said it doesn't know at this point if any patients were given the counterfeit version of the drug, the Associated Press reported. Avastin is used to treat colorectal, brain, lung and kidney cancers.

Medical practices that have received any products from Medical Device King, Pharmalogical or Taranis Medical (another company associated with Pharmalogical) should quit using these products because they might prove hazardous or ineffective, the FDA said.

Anyone with these medicines also should contact the FDA's Office of Criminal Investigations to arrange for pickup.

This is the third case of counterfeit Avastin being sold in the United States in the past year, the AP reported.

In February 2012, the agency said it was investigating a batch of counterfeit Avastin distributed to doctors in several states. In April 2012, the FDA warned doctors about fake Avastin distributed by a U.K. company.

Those two cases appeared to involve different networks of distributors than the latest episode, the AP reported.

More information

The MedlinePlus Medical Encyclopedia has more about Avastin (bevacizumab).

-- Robert Preidt

SOURCES: U.S. Food and Drug Administration, news release, Feb. 5, 2013; Associated Press


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. UCSF chancellor issues call-to-arms to patient advocates
2. Radiologists rank themselves as less than competent on health policy issues
3. Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
4. FDA Issues Multiple Sclerosis Drug Alert
5. Quality of care, other issues may cause worse results in black prostate cancer surgery patients
6. U.S. Task Force Issues Blood Pressure Guidelines
7. Internists in Washington to discuss patient and professional issues in meetings on Capitol Hill
8. Cheaper drug could lead to serious eye issues
9. Insulite Labs announces the launch of the PCOS Inspiration Hour, a one hour virtual gathering place for women with PCOS and other women’s health issues to come together.
10. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
11. What Men Should Know About Veins: Varicose Veins and Venous Disease are Real Medical Issues
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Issues Another Warning on Fake Version of Cancer Drug Avastin
(Date:6/27/2016)... , ... June 27, 2016 , ... TopConsumerReviews.com recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016 /PRNewswire/ ... pulmonary function testing company, is now able to perform sophisticated lung ... ndd Medical Technologies , Inc. Patients are ... labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients like ... any needed testing done in the comfort of her own home. ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
Breaking Medicine Technology: